HSITF
Price
$0.12
Change
-$0.01 (-7.69%)
Updated
Dec 30 closing price
Capitalization
1.59M
IGXT
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
May 16 closing price
Capitalization
29.17M
64 days until earnings call
Ad is loading...

HSITF vs IGXT

Header iconHSITF vs IGXT Comparison
Open Charts HSITF vs IGXTBanner chart's image
Hadasit Bio Holdings
Price$0.12
Change-$0.01 (-7.69%)
Volume$24.86K
Capitalization1.59M
IntelGenx Technologies
Price$0.17
Change-$0.00 (-0.00%)
Volume$37.23K
Capitalization29.17M
HSITF vs IGXT Comparison Chart
Loading...
HSITF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HSITF vs. IGXT commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSITF is a Hold and IGXT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (HSITF: $0.12 vs. IGXT: $0.17)
Brand notoriety: HSITF and IGXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HSITF: 39% vs. IGXT: 100%
Market capitalization -- HSITF: $1.59M vs. IGXT: $29.17M
HSITF [@Biotechnology] is valued at $1.59M. IGXT’s [@Biotechnology] market capitalization is $29.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSITF’s FA Score shows that 0 FA rating(s) are green whileIGXT’s FA Score has 1 green FA rating(s).

  • HSITF’s FA Score: 0 green, 5 red.
  • IGXT’s FA Score: 1 green, 4 red.
According to our system of comparison, IGXT is a better buy in the long-term than HSITF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSITF’s TA Score shows that 2 TA indicator(s) are bullish.

  • HSITF’s TA Score: 2 bullish, 4 bearish.

Price Growth

HSITF (@Biotechnology) experienced а 0.00% price change this week, while IGXT (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

IGXT is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IGXT($29.2M) has a higher market cap than HSITF($1.59M). HSITF (0.000) and IGXT (0.000) have similar YTD gains . HSITF has higher annual earnings (EBITDA): -7.66M vs. IGXT (-8.16M). HSITF has more cash in the bank: 5.47M vs. IGXT (772K). HSITF has less debt than IGXT: HSITF (1.69M) vs IGXT (16.5M). IGXT has higher revenues than HSITF: IGXT (1.05M) vs HSITF (27K).
HSITFIGXTHSITF / IGXT
Capitalization1.59M29.2M5%
EBITDA-7.66M-8.16M94%
Gain YTD0.0000.000-
P/E RatioN/AN/A-
Revenue27K1.05M3%
Total Cash5.47M772K708%
Total Debt1.69M16.5M10%
FUNDAMENTALS RATINGS
HSITF vs IGXT: Fundamental Ratings
HSITF
IGXT
OUTLOOK RATING
1..100
9948
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8169
P/E GROWTH RATING
1..100
915
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HSITF's Valuation (60) in the null industry is in the same range as IGXT (89). This means that HSITF’s stock grew similarly to IGXT’s over the last 12 months.

HSITF's Profit vs Risk Rating (100) in the null industry is in the same range as IGXT (100). This means that HSITF’s stock grew similarly to IGXT’s over the last 12 months.

HSITF's SMR Rating (98) in the null industry is in the same range as IGXT (100). This means that HSITF’s stock grew similarly to IGXT’s over the last 12 months.

IGXT's Price Growth Rating (69) in the null industry is in the same range as HSITF (81). This means that IGXT’s stock grew similarly to HSITF’s over the last 12 months.

IGXT's P/E Growth Rating (5) in the null industry is significantly better than the same rating for HSITF (91). This means that IGXT’s stock grew significantly faster than HSITF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSITFIGXT
RSI
ODDS (%)
Bullish Trend 7 days ago
14%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
11%
N/A
Momentum
ODDS (%)
Bearish Trend 7 days ago
33%
N/A
MACD
ODDS (%)
Bearish Trend 7 days ago
31%
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
10%
Bullish Trend 7 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
16%
Bullish Trend 7 days ago
70%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
HSITF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTH78.522.87
+3.79%
Meritage Homes Corporation
MATH1.520.05
+3.44%
Metalpha Technology Holding Limited
ARTNA30.230.32
+1.07%
Artesian Resources Corp
SO82.050.18
+0.22%
Southern Company (The)
LUMN5.31-0.05
-0.93%
Lumen Technologies

HSITF and

Correlation & Price change

A.I.dvisor tells us that HSITF and JWCTF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSITF and JWCTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSITF
1D Price
Change %
HSITF100%
N/A
JWCTF - HSITF
25%
Poorly correlated
N/A
CGEM - HSITF
21%
Poorly correlated
-9.33%
AEON - HSITF
21%
Poorly correlated
-9.93%
FAMDF - HSITF
5%
Poorly correlated
-2.50%
IGXT - HSITF
5%
Poorly correlated
N/A
More

IGXT and

Correlation & Price change

A.I.dvisor tells us that IGXT and ACET have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IGXT and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGXT
1D Price
Change %
IGXT100%
N/A
ACET - IGXT
28%
Poorly correlated
+3.96%
DTIL - IGXT
27%
Poorly correlated
-6.27%
EDIT - IGXT
25%
Poorly correlated
-1.72%
CRSP - IGXT
24%
Poorly correlated
-1.26%
BCRX - IGXT
24%
Poorly correlated
-8.83%
More